Page last updated: 2024-08-23

paroxetine and Psychoses, Drug

paroxetine has been researched along with Psychoses, Drug in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, S; Ito, T; Kaneko, Y; Kashiwa, A; Nishikawa, T; Umino, A1
Christensen, RC1
Bastani, AJ; Bastani, JB; Troester, MM1
Bartel, RL; Goodhue, A; Smith, NB1

Other Studies

4 other study(ies) available for paroxetine and Psychoses, Drug

ArticleYear
Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:3

    Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Fluoxetine; Head Movements; Locomotion; Methamphetamine; Mice; Paroxetine; Psychoses, Substance-Induced; Secondary Prevention; Selective Serotonin Reuptake Inhibitors

2007
Adverse interaction of paroxetine and cyproheptadine.
    The Journal of clinical psychiatry, 1995, Volume: 56, Issue:9

    Topics: Cyproheptadine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Paroxetine; Psychoses, Substance-Induced

1995
Serotonin syndrome and fluvoxamine: a case study.
    The Nebraska medical journal, 1996, Volume: 81, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Syndrome; Time Factors

1996
Exacerbation of psychosis by phenylpropanolamine.
    The American journal of psychiatry, 2000, Volume: 157, Issue:6

    Topics: Adult; Female; Hallucinations; Humans; Methamphetamine; Nasal Decongestants; Paranoid Disorders; Paroxetine; Perphenazine; Phenylpropanolamine; Psychoses, Substance-Induced; Recurrence; Substance-Related Disorders

2000